(Q53249666)

English

Graft-versus-host and graft-versus-leukemia reactions: a summary of the Seventh International Symposium held in Garmisch-Partenkirchen, Germany, February 22nd-25th, 2006, Tolerance and Immunity, an update on lymphoid malignancies.

scientific article published on 18 September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

Graft-versus-host and graft-versus-leukemia reactions: a summary of the Seventh International Symposium held in Garmisch-Partenkirchen, Germany, February 22nd-25th, 2006, Tolerance and Immunity, an update on lymphoid malignancies. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

author name string

Munker R

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

Reibke R

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

Kolb HJ

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

language of work or name

0 references

publication date

18 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

38

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

9

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

593-607

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705499

0 references

Attenuation of cell adhesion in lymphocytes is regulated by CYTIP, a protein which mediates signal complex sequestration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

DNA fusion gene vaccines against cancer: from the laboratory to the clinic.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

DNA fusion vaccines induce targeted epitope-specific CTLs against minor histocompatibility antigens from a normal or tolerized repertoire

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Virus reconstituted from infectious bacterial artificial chromosome (BAC)-cloned murine gammaherpesvirus 68 acquires wild-type properties in vivo only after excision of BAC vector sequences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Cloning of herpesviral genomes as bacterial artificial chromosomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Mechanisms of B-cell lymphoma pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Determinants of antileukemia effects of allogeneic NK cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Graft-versus-leukemia reactions in allogeneic chimeras

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Clinical significance of minimal residual disease, as assessed by different techniques, after stem cell transplantation for chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Real-time single-molecule imaging of the infection pathway of an adeno-associated virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Eradication of B-CLL by autologous and allogeneic host nonreactive anti-third-party CTLs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

The fate of human Langerhans cells in hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

21 January 2018

Dendritic cells regulate T-cell deattachment through the integrin-interacting protein CYTIP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

7 January 2021

based on heuristic

inferred from DOI database lookup

Adoptive immunotherapy for EBV-associated malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithymocyte globulin induces complement-dependent cell lysis and caspase-dependent apoptosis in myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary allogeneic T-cell responses against mantle cell lymphoma antigen-presenting cells for adoptive immunotherapy after stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

7 January 2021

based on heuristic

inferred from DOI database lookup

An update on graft-versus-host and graft-versus-leukemia reactions: a summary of the sixth International Symposium held in Schloss Ellmau, Germany, January 22-24, 2004

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoimmunotherapy--towards real progress in the treatment of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of trifunctional bispecific antibodies to prevent graft versus host disease induced by allogeneic lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705499

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705499

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/16980992

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53249666&oldid=1465436701"